Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chinook Therapeutics, Inc.

40.39
0.0000
Volume:- -
Turnover:- -
Market Cap:2.90B
PE:-11.49
High:40.39
Open:40.39
Low:40.39
Close:40.39
Loading ...
Nov 30, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 08, 2021

Major Issues Report

8-K - Current report
Nov 08, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 07, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 09, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2021

Major Issues Report

8-K - Current report
Apr 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 07, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 07, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 07, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 20, 2020

Major Issues Report

8-K - Current report